Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Oct 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 109778601000001117 | Procainamide 1g modified-release tablets (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 109778701000001110 | Procainamide 1g modified-release tablets | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Procainamide 1g modified-release tablets | Is a | Product containing procainamide | false | Inferred relationship | Existential restriction modifier | ||
| Procainamide 1g modified-release tablets | Has active ingredient | Procainamide | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Procainamide 1g modified-release tablets 100 tablet | Has VMP | False | Procainamide 1g modified-release tablets | Inferred relationship | Existential restriction modifier | |
| Procanbid 1g modified-release tablets (Monarch Pharmaceuticals, Inc) | Is a | False | Procainamide 1g modified-release tablets | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR